What is NVO's current stock price?

As of now, NVO is trading at $52.96, with a daily change of -0.48%.

What are the risks associated with NVO stock?

NVO Key risk is its Low Risk Level, .

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Earnings Calendar Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

NVO Stock Analysis & IQ Rating | Novo Nordisk A/S

NVO

Novo Nordisk A/S

$52.96

-$0.26 | -0.48%

Create Alerts

Overview

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

52W High

$ 114.19

MKT CAP

$ 174.84B

52W Low

$ 45.05

VOL

$ 7.71M

P/E Ratio

13.67

AVG VOL

$ 13.35M

RSI

36.72

TREND

Sideways

NVO Stock IQ

Login to see Novo Nordisk A/S (NVO) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

NVO Target Price

Login to display

Strengths

NVO Rewards

Upgraded on attractively valued

NVO Rewards

Trading below its fair value

NVO Rewards

Investors confidence is positive

Risk Analysis

NVO Risk Analysis

Earnings are forecast to decrease

Chart

$55.5 (-4.58%)

$48.19 (+9.90%)

$72.04 (-26.49%)

$107.63 (-50.79%)

1year

6month

3month

1month

NVO Risk Level

NVO has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Investors losing confidence

LOW

HIGH

NVO Analysts Opinion

NVO overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

NVO Analysts Opinion

NVO Analysts opinion is positive and also has improved from the past 3 months

NVO Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

81%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

57%

71%

NVO Street Opinion

NVO Street view is extremely bullish and have positive views on the near-term outlook

NVO Performance Sentiment

Sentiments overview associated with NVO events and the stock performance.

81%

17%

Positive

Negative

66 out of 81
events present

14 out of 81
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$53.37

Resistance
Price

$53.37

Current Price Range

$61.85

Show methods +

Linked to NVO

IQ

Close Price

Change

LLY

4.20

827.52

+0.52%

LEXX

1.90

0.94

+3.20%

PFE

4.08

24.76

+0.36%

VKTX

3.79

34.42

+1.47%

SNY

3.91

51.64

+4.28%

NVO Latest Analysis +

Novo Nordisks new chairman has carte blanche after board clear-out.

Today

$52.96 | -0.48%

Activity

Options Corner: A Reliable Quant Signal Just Flashed Again For Pharma Giant Novo Nordisk. At first glance ) doesn'.t appear at all enticing. Down roughly 11% in the trailing month NVO stock has been a victim of broader market pressure. But it'.s also the red ink that makes the pharmaceutical giant an enticing opportunity for options traders.Every day my routine involves scanning hundreds of stocks to find the most compelling opportunities to discuss. Prior to my exploration of quantitati

Thu Oct 23, 2025

$53.23 | -0.25%

Momentum

How Will Ozempic and Wegovy Sales Aid NVOs Upcoming Q3 Results?. Novo Nordisks Q3 results hinge on Ozempic and Wegovy sales as demand growth slows amid rivalry market limits and compounded drug headwinds.

Thu Oct 23, 2025

$53.23 | -0.25%

Potential

Is Novo Nordisk (NVO) The Best Weight-Loss Stock to Buy?. We recently published 10 Trending Stocks Moving These Days. Novo Nordisk A/S (NYSE:NVO) is one of the trending stocks moving these days. Karen Finerman CEO &. Co-founder Metropolitan Capital Advisors said in a recent program on CNBC that she likes NVO amid the companys weight-loss drug business. All this talk about GLP-1s? No Im not [….]

Thu Oct 23, 2025

$53.23 | -0.25%

Potential

J.P. Morgan Maintains a Buy on Novo Nordisk (NVO). Novo Nordisk A/S (NYSE:NVO) is one of the best long term low volatility stocks to buy right now. J.P. Morgan analyst Richard Vosser maintained a Buy rating on Novo Nordisk A/S (NYSE:NVO) in a report released on October 17 setting a price target of DKK500. The rating followed Novo Nordisks (NYSE:NVO) announcement on October 15 that [….]

Thu Oct 23, 2025

$53.23 | -0.25%

Rating

Novo Nordisk A/S (NVO): A Case Theory . We came across a ish thesis on Novo Nordisk A/S on The Analyst’.s Journals Substack by A_Capital. In this article we will summarize the s thesis on NVO. Novo Nordisk A/S’.s share was trading at $56.72 as of October 15th. NVOs trailing and forward P/E were 14.98 and 14.08 respectively according to Yahoo Finance. Novo Nordisk A/S represents a compelling long-term growth [….]

Wed Oct 22, 2025

$53.38 | -2.56%

Potential

NVO Stock Falls Amid Governance Shift as Foundation Seeks New Board. Novo Nordisk stock slides as the Novo Nordisk Foundation pushes a sweeping board overhaul signaling a new era in governance and strategic direction.

Wed Oct 22, 2025

$53.38 | -2.56%

Momentum

NVOs Rybelsus Gets FDA Nod to Reduce Heart Risk in Diabetes Patients. Novo Nordisk secures FDA approval for Rybelsus as the first oral GLP-1 therapy proven to cut major heart risks in adults with type II diabetes.

Tue Oct 21, 2025

$54.78 | -1.73%

Activity

Healthy Returns: A key step forward for Novo Nordisks GLP-1 pill. A closely watched pill from Novo Nordisk just scored an approval for slashing cardiovascular risks while Mark Cuban gives Trump credit on drug prices.

Tue Oct 21, 2025

$54.78 | -1.73%

Activity

Novo Nordisk A/S (NVO) Discusses Extraordinary General Meeting on Proposed Board Changes and Governance Transcript.

Tue Oct 21, 2025

$54.78 | -1.73%

Activity

FAQ About NVO Stock Insights

What is NVO current stock price?

What are NVO stock strengths?

What risks are associated with NVO stock?

When is NVO next earnings report?

What is NVO market cap and volume?

What is NVO's current Stock IQ?

Should I buy NVO stock right now?

Is NVO a Strong Buy right now?

What does a 'Strong Buy' rating mean for NVO?

What does a 'Strong Sell' rating mean for NVO?

What factors influence NVO's Stock IQ?

Explore our NVO Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored NVO Stock Strategies
Effective Risk Management

FIND US ON

Receive our NVO Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

NVO

Novo Nordisk A/S

Current Price

$52.96

-$0.26 | -0.48%

52W High

$ 114.19

MKT CAP

$ 174.84B

52W Low

$ 45.05

VOL

$ 7.71M

P/E Ratio

13.67

AVG VOL

$ 13.35M

RSI

36.72

TREND

Sideways

Create Alerts

Overview

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

NVO Rewards

Upgraded on attractively valued

NVO Rewards

Trading below its fair value

NVO Rewards

Investors confidence is positive

Risk Analysis

NVO Risk Analysis

Earnings are forecast to decrease

Linked to NVO

Symbol

IQ

Close

Change

LLY

4.20

827.52

+0.52%

LEXX

1.90

0.94

+3.20%

PFE

4.08

24.76

+0.36%

VKTX

3.79

34.42

+1.47%

SNY

3.91

51.64

+4.28%

NVO Stock IQ

Login to unlock Novo Nordisk A/S (NVO) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$55.5 (-4.58%)

$48.19 (+9.90%)

$72.04 (-26.49%)

$107.63 (-50.79%)

1year

6month

3month

1month

NVO Analysts Opinion

NVO Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

NVO Analysts Opinion

NVO Analysts opinion is positive and also has improved from the past 3 months

NVO Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

81%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

57%

71%

NVO Street Opinion

NVO Street view is extremely bullish and have positive views on the near-term outlook

NVO Risk Level

NVO has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Investors losing confidence

LOW

HIGH

NVO Performance Sentiment

Sentiments overview associated with NVO events and the stock performance.

81%

17%

Positive

Negative

66 out of 81
events present

14 out of 81
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$53.37

Resistance
Price

$53.37

Current Price Range

$61.85

Show methods +

NVO Latest Analysis

Novo Nordisks new chairman has carte blanche after board clear-out.

Today

$52.96 | -0.48%

Activity

Options Corner: A Reliable Quant Signal Just Flashed Again For Pharma Giant Novo Nordisk. At first glance ) doesn'.t appear at all enticing. Down roughly 11% in the trailing month NVO stock has been a victim of broader market pressure. But it'.s also the red ink that makes the pharmaceutical giant an enticing opportunity for options traders.Every day my routine involves scanning hundreds of stocks to find the most compelling opportunities to discuss. Prior to my exploration of quantitati

Thu Oct 23, 2025

$53.23 | -0.25%

Momentum

How Will Ozempic and Wegovy Sales Aid NVOs Upcoming Q3 Results?. Novo Nordisks Q3 results hinge on Ozempic and Wegovy sales as demand growth slows amid rivalry market limits and compounded drug headwinds.

Thu Oct 23, 2025

$53.23 | -0.25%

Potential

Is Novo Nordisk (NVO) The Best Weight-Loss Stock to Buy?. We recently published 10 Trending Stocks Moving These Days. Novo Nordisk A/S (NYSE:NVO) is one of the trending stocks moving these days. Karen Finerman CEO &. Co-founder Metropolitan Capital Advisors said in a recent program on CNBC that she likes NVO amid the companys weight-loss drug business. All this talk about GLP-1s? No Im not [….]

Thu Oct 23, 2025

$53.23 | -0.25%

Potential

J.P. Morgan Maintains a Buy on Novo Nordisk (NVO). Novo Nordisk A/S (NYSE:NVO) is one of the best long term low volatility stocks to buy right now. J.P. Morgan analyst Richard Vosser maintained a Buy rating on Novo Nordisk A/S (NYSE:NVO) in a report released on October 17 setting a price target of DKK500. The rating followed Novo Nordisks (NYSE:NVO) announcement on October 15 that [….]

Thu Oct 23, 2025

$53.23 | -0.25%

Rating

Novo Nordisk A/S (NVO): A Case Theory . We came across a ish thesis on Novo Nordisk A/S on The Analyst’.s Journals Substack by A_Capital. In this article we will summarize the s thesis on NVO. Novo Nordisk A/S’.s share was trading at $56.72 as of October 15th. NVOs trailing and forward P/E were 14.98 and 14.08 respectively according to Yahoo Finance. Novo Nordisk A/S represents a compelling long-term growth [….]

Wed Oct 22, 2025

$53.38 | -2.56%

Potential

NVO Stock Falls Amid Governance Shift as Foundation Seeks New Board. Novo Nordisk stock slides as the Novo Nordisk Foundation pushes a sweeping board overhaul signaling a new era in governance and strategic direction.

Wed Oct 22, 2025

$53.38 | -2.56%

Momentum

NVOs Rybelsus Gets FDA Nod to Reduce Heart Risk in Diabetes Patients. Novo Nordisk secures FDA approval for Rybelsus as the first oral GLP-1 therapy proven to cut major heart risks in adults with type II diabetes.

Tue Oct 21, 2025

$54.78 | -1.73%

Activity

Healthy Returns: A key step forward for Novo Nordisks GLP-1 pill. A closely watched pill from Novo Nordisk just scored an approval for slashing cardiovascular risks while Mark Cuban gives Trump credit on drug prices.

Tue Oct 21, 2025

$54.78 | -1.73%

Activity

Novo Nordisk A/S (NVO) Discusses Extraordinary General Meeting on Proposed Board Changes and Governance Transcript.

Tue Oct 21, 2025

$54.78 | -1.73%

Activity

Discover NVO Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of NVO. We're here to help you make informed investment decisions today.

FIND US ON

Receive our NVO Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

NVO Stock trends

NVO Stock performance

NVO Stock analysis

NVO investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing NVO

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing NVO

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

NVO Stock Analysis & IQ Rating | Novo Nordisk A/S

NVO Stock IQ

NVO Target Price

NVO Risk Level

NVO Analysts Opinion

NVO Street Consensus

NVO Performance Sentiment

Technical Price Levels

Explore our NVO Stock insights

Receive our NVO Daily Alerts

NVO Stock IQ

NVO Street Consensus

NVO Risk Level

Technical Price Levels

Discover NVO Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of NVO. We're here to help you make informed investment decisions today.

Receive our NVO Daily Alerts

NVO Runner Alarm